AAPL   317.86 (+0.36%)
MSFT   179.09 (-1.37%)
AMZN   2,395.66 (-1.08%)
NVDA   338.55 (-2.91%)
CGC   20.32 (+1.55%)
BABA   200.85 (-0.44%)
MU   45.85 (+0.11%)
TSLA   817.77 (-0.13%)
AMD   52.31 (-1.65%)
T   31.60 (+2.50%)
ACB   15.74 (+0.83%)
F   6.06 (+3.77%)
DIS   123.53 (+2.13%)
BAC   25.62 (+5.48%)
AAPL   317.86 (+0.36%)
MSFT   179.09 (-1.37%)
AMZN   2,395.66 (-1.08%)
NVDA   338.55 (-2.91%)
CGC   20.32 (+1.55%)
BABA   200.85 (-0.44%)
MU   45.85 (+0.11%)
TSLA   817.77 (-0.13%)
AMD   52.31 (-1.65%)
T   31.60 (+2.50%)
ACB   15.74 (+0.83%)
F   6.06 (+3.77%)
DIS   123.53 (+2.13%)
BAC   25.62 (+5.48%)
AAPL   317.86 (+0.36%)
MSFT   179.09 (-1.37%)
AMZN   2,395.66 (-1.08%)
NVDA   338.55 (-2.91%)
CGC   20.32 (+1.55%)
BABA   200.85 (-0.44%)
MU   45.85 (+0.11%)
TSLA   817.77 (-0.13%)
AMD   52.31 (-1.65%)
T   31.60 (+2.50%)
ACB   15.74 (+0.83%)
F   6.06 (+3.77%)
DIS   123.53 (+2.13%)
BAC   25.62 (+5.48%)
AAPL   317.86 (+0.36%)
MSFT   179.09 (-1.37%)
AMZN   2,395.66 (-1.08%)
NVDA   338.55 (-2.91%)
CGC   20.32 (+1.55%)
BABA   200.85 (-0.44%)
MU   45.85 (+0.11%)
TSLA   817.77 (-0.13%)
AMD   52.31 (-1.65%)
T   31.60 (+2.50%)
ACB   15.74 (+0.83%)
F   6.06 (+3.77%)
DIS   123.53 (+2.13%)
BAC   25.62 (+5.48%)
Log in

LON:ONCOncimmune News Headlines

GBX 93.70
-2.80 (-2.90 %)
(As of 05/27/2020 08:03 AM ET)
Add
Compare
Today's Range
93.50
Now: GBX 93.70
99
50-Day Range
47.50
MA: GBX 78.55
99
52-Week Range
30
Now: GBX 93.70
111.45
Volume28,460 shs
Average Volume33,554 shs
Market Capitalization£59.50 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Oncimmune (LON ONC) News Headlines

Source:
DateHeadline
Oncimmune (LON:ONC) Receives "Corporate" Rating from FinnCapOncimmune (LON:ONC) Receives "Corporate" Rating from FinnCap
www.americanbankingnews.com - May 21 at 2:05 PM
Oncimmune Signs Drug Development Deal With US Biopharmaceutical FirmOncimmune Signs Drug Development Deal With US Biopharmaceutical Firm
www.lse.co.uk - May 15 at 12:43 AM
BRIEF-Oncimmune Signs Antigen Targeting Collaboration To Support Drug DevelopmentBRIEF-Oncimmune Signs Antigen Targeting Collaboration To Support Drug Development
www.reuters.com - May 12 at 8:02 AM
Oncimmune (LON:ONC) Receives Corporate Rating from FinnCapOncimmune (LON:ONC) Receives Corporate Rating from FinnCap
www.americanbankingnews.com - May 12 at 7:01 AM
Insider Buying: Oncimmune Holdings PLC (LON:ONC) Insider Buys 18,000 Shares of StockInsider Buying: Oncimmune Holdings PLC (LON:ONC) Insider Buys 18,000 Shares of Stock
www.americanbankingnews.com - May 6 at 11:16 AM
BRIEF-Oncimmune Announces Commercial Launch In U.S.BRIEF-Oncimmune Announces Commercial Launch In U.S.
www.reuters.com - March 4 at 7:28 PM
Oncimmune EarlyCDT Lung Test Launched In US By Commercial PartnerOncimmune EarlyCDT Lung Test Launched In US By Commercial Partner
www.lse.co.uk - March 4 at 9:27 AM
Oncimmune Half-Year Loss Widens As Business "Reshaping" Ups ExpensesOncimmune Half-Year Loss Widens As Business "Reshaping" Ups Expenses
www.lse.co.uk - February 12 at 9:01 AM
BRIEF-Oncimmune Holdings Says Revenue For HY Was £0.31 MlnBRIEF-Oncimmune Holdings Says Revenue For HY Was £0.31 Mln
www.reuters.com - February 12 at 4:00 AM
Oncimmune Reports Study Results For Cancer Test ProductOncimmune Reports Study Results For Cancer Test Product
www.lse.co.uk - January 28 at 1:37 PM
Consortium of Liver Cancer Industry LeadersConsortium of Liver Cancer Industry Leaders
www.lse.co.uk - January 23 at 8:58 PM
What Kind Of Shareholders Own Oncimmune Holdings Plc (LON:ONC)?What Kind Of Shareholders Own Oncimmune Holdings Plc (LON:ONC)?
finance.yahoo.com - November 15 at 9:03 AM
Biodesix Completes Acquisition of Oncimmune Assets in the United StatesBiodesix Completes Acquisition of Oncimmune Assets in the United States
finance.yahoo.com - November 2 at 12:28 AM
Oncimmune Share Price (ONC)Oncimmune Share Price (ONC)
www.lse.co.uk - October 18 at 11:58 AM
CORRECT (Sep 20): Oncimmune Secures EUR8.5 Million Credit FacilityCORRECT (Sep 20): Oncimmune Secures EUR8.5 Million Credit Facility
www.morningstar.co.uk - September 25 at 8:19 AM
Oncimmune Adds Former Glaxo And Astra Seniors To Leadership RanksOncimmune Adds Former Glaxo And Astra Seniors To Leadership Ranks
www.morningstar.co.uk - September 23 at 3:53 PM
Oncimmune "Thrilled" With EarlyCDT Lung Cancer Test Trial ResultOncimmune "Thrilled" With EarlyCDT Lung Cancer Test Trial Result
www.morningstar.co.uk - September 9 at 9:26 AM
Oncimmune Further Expands EarlyCDT Lung Sales In Spain Through VithasOncimmune Further Expands EarlyCDT Lung Sales In Spain Through Vithas
www.morningstar.co.uk - July 15 at 11:07 AM
Oncimmune Partners With R-Pharm To Offer EarlyCDT Lung Test In RussiaOncimmune Partners With R-Pharm To Offer EarlyCDT Lung Test In Russia
www.morningstar.co.uk - July 4 at 10:56 AM
Boulder lung-diagnostics company acquires part of publicly-traded U.K. firmBoulder lung-diagnostics company acquires part of publicly-traded U.K. firm
www.bizjournals.com - June 28 at 4:04 PM
Oncimmune Partners With Biodesix To Expand Use Of EarlyCDT Lung In USOncimmune Partners With Biodesix To Expand Use Of EarlyCDT Lung In US
www.morningstar.co.uk - June 28 at 10:53 AM
UK biotechs seek to speed up cancer detectionUK biotechs seek to speed up cancer detection
finance.yahoo.com - June 7 at 7:36 PM
Oncimmune Holdings Reports Positive Lung Cancer Study ResultsOncimmune Holdings Reports Positive Lung Cancer Study Results
www.morningstar.co.uk - June 4 at 11:25 AM
Oncimmune Gains Regulatory Approval For EarlyCDT-Lung In IsraelOncimmune Gains Regulatory Approval For EarlyCDT-Lung In Israel
www.morningstar.co.uk - May 15 at 11:09 AM
Oncimmune Lung Cancer Test To Be Sold In Spanish Private HospitalsOncimmune Lung Cancer Test To Be Sold In Spanish Private Hospitals
www.morningstar.co.uk - March 25 at 11:29 AM
Oncimmune Buys Protagen Diagnostics In EUR4 Million All-Share Deal (ALLISS)Oncimmune Buys Protagen Diagnostics In EUR4 Million All-Share Deal (ALLISS)
www.morningstar.co.uk - March 19 at 11:51 AM
Oncimmune Announces the Acquisition of Protagen Diagnostics AG, a Leader in Personalised Immuno-ProfilingOncimmune Announces the Acquisition of Protagen Diagnostics AG, a Leader in Personalised Immuno-Profiling
finance.yahoo.com - March 19 at 11:51 AM
Oncimmune Signs US Distribution Deal With Choice Provider NetworkOncimmune Signs US Distribution Deal With Choice Provider Network
www.morningstar.co.uk - December 20 at 10:46 AM
Oncimmune Signs Agreement with America’s Choice Provider Network to Expand Access to its Blood Tests for the Early Detection of Lung and Liver CancersOncimmune Signs Agreement with America’s Choice Provider Network to Expand Access to its Blood Tests for the Early Detection of Lung and Liver Cancers
finance.yahoo.com - December 20 at 10:46 AM
This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.